Importance of delaying balloon angioplasty in patients with unstable angina pectoris

Angioplasty in patients with unstable coronary artery disease is associated with higher complication rates compared with patients with stable disease. In this report we describe our results from a group of patients with unstable disease (unstable angina pectoris and postmyocardial infarction) where a strategy of delaying angioplasty for >5 days after admission was undertaken. Included are 2069 consecutive patients: 1197 treated for stable angina pectoris and 872 treated during admission for unstable angina or myocardial infarction. There was no difference between the two groups in angioplasty success (92.1% stable, 92.3% unstable), failure to dilate without complication (6.4% stable, 6.1 % unstable), or in the rate of major complications: death (0.5% stable, 1.1% unstable), Q-wave myocardial infarction (0.9% stable, 1.1% unstable), and emergency coronary artery bypass (0.6% stable, 0.3% unstable). The duration of hospitalization following angioplasty was longer in the unstable group (5.6 ± 8.1 days vs. 4.2 ± 4.1 days; p < 0.001) because of longer duration of hep-arin infusion. There was no difference between groups in minor complications such as groin hematoma and pseudoa-neurysm, renal failure, or infections. It was concluded that delaying angioplasty in unstable patients for > 5 days after admission is a safe and effective therapeutic strategy for this group of patients. The need for prolonged heparin infusion after angioplasty is increased in unstable patients and thus the duration of hospitalization after the procedure is longer.     

Occurrence of angina pectoris prior to acute myocardial infarction and its relation to prognosis

In 917 patients with acute myocardial infarction (AMI) we evaluatedthe impact of previous angina pectoris on the prognosis. Thirty-fourpercent of the patients had chronic angina prior to AMI, and22% had angina pectoris of short duration. Patients with chronicangina pectoris differed from the remaining patients havinga more frequent previous history of AMI, diabetes mellitus,hypertension, and congestive heart failure. They less frequentlydeveloped a Q-wave AMI, and had smaller infarcts according tomaximum serum-enzyme activity as compared with the remainingpatients. They had a higher one-year mortality rate (36%) ascompared with those having angina pectoris of short duration(22%), and those with no angina pectoris (26%). Their reinfarctionrate was also higher (26%) as compared with that in the othertwo groups (15% and 9% respectively). In a multivariate analysisconsidering age, sex, clinical history, initial symptoms, initialelectrocardiogram and estimated infarct size, previous chronicangina pectoris was not an independent risk factor for death,but was independently associated with the risk of reinfarction(P<0.001) Among patients with a history of angina pectoristhe outcome was related to medication prior to onset of AMIand at discharge from hospital. Patients in whom beta-blockerswere prescribed at discharge had a one-year mortality of 13%as compared with 30% in the remaining patients (P<0.001).     

Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris

Among 252 patients hospitalized for unstable angina in 1982 and 1983, 54 (21%) had undergone coronary artery bypass grafting (CABG) a mean of 55 months earlier (range 1 to 168) (CABG patients). This group was compared with a group of 54 randomly selected patients with unstable angina without previous CABG (control patients). The 2 groups did not differ with respect to clinical characteristics at admission or hospital course. Coronary arteriograms, recorded in all but 4 CABG patients, revealed multivessel stenoses of at least 70% luminal diameter in 40 CABG and 32 control patients (p < 0.05), but when patent grafts were considered, the groups were comparable. Overall, 48 of 112 grafts were totally occluded and 14 had stenoses at least 70% in diameter. Complete or almost complete revascularization was feasible in 39 of 52 control and only 9 of 42 CABG patients (p < 0.001). By 1 year, 46 control patients and 20 CABG patients had undergone CABG or coronary angioplasty (p < 0.001); 42 of 53 control patients and only 22 of 50 CABG patients were in functional class 0 or I (p < 0.001). Cumulative adverse events (5 deaths, 10 myocardial infarctions and 15 cases of recurrent unstable angina) were more frequent in the CABG group, 20 vs 10 (p < 0.05). Thus, although their clinical features and hospital course are similar, patients with unstable angina who have undergone previous CABG do not do as well as other patients with unstable angina because they are less amenable to revascularization.     

Rate and mode of death during five years of follow-up among patients with acute chest pain with and without a history of diabetes mellitus

In order to determine the effect of diabetes on the mortality rate and mode of death during 5 years of follow-up among patients who came to the emergency department with acute chest pain or other symptoms suggestive of acute myocardial infarction (AMI), all patients thus presenting to one single hospital during a period of 21 months were followed for 5 years. In total 5230 patients were included, of whom 402 (8 %) had a history of diabetes. Patients with diabetes differed from those without by being older, having a higher prevalence of previously diagnosed cardiovascular diseases, having less symptoms of chest pain and more symptoms of acute severe heart failure, and more electrocardiographic (ECG) abnormalities on admission. Diabetic patients had a 5-year mortality of 53.5 % as compared with 23.3 % among non-diabetic patients (p < 0.001; adjusted risk ratio 1.60; 95% confidence limits 1.35–1.90). Among diabetic patients the following appeared as independent predictors of death: age (p < 0.001), ST-segment elevation on admission (p < 0.001), a history of myocardial infarction (p < 0.05), and a non-pathological ECG on admission (p < 0.001). We conclude that among diabetic patients admitted to the emergency department with acute chest pain or other symptoms suggestive of AMI more than 50 % are dead 5 years later. Future research should focus on interventions in order to reduce their mortality. © 1998 John Wiley & Sons, Ltd.     

The prognostic value of maximal exercise testing soon after first myocardial infarction

The prognostic value of ST-segment depression during maximalexercise test performed in the third to fourth week after acutemyocardial infarction (AMI), was studied in 126 consecutivepatients with no evidence of previous myocardial infarction,unstable angina pectoris or severe heart failure. All patientson average increased their pressure-rate product by 2.6 andno complications occurred. Within the first year of follow-up,major cardiac events occurred in 9 patients (20%), and werefatal in 6 (13%), of the 46 patients who developed ST-segmentdepression during exercise. Only 3 major cardiac events (4%)occurred in the 80 patients without exercise induced ST-segmentdepression. Depression of the ST-segment on maximal exercisewas a significant predictor of subsequent cardiac events inthese survivors of first AMI.     

12-month outcomes of percutaneous and surgical revascularization in acute coronary syndromes without ST-segment elevation in patients with multivessel coronary artery disease

Early invasive strategy is one of two methods of treatment of acute coronary syndromes without ST-segment elevation (NSTEACS). We aimed at assessing 12-month outcomes and quality of life in patients with NSTEACS and multivessel coronary artery disease (CAD) who underwent percutaneous or surgical revascularization. Analyzed group comprised 412 patients (92%) who were qualified for invasive treatment based on coronary angiography performed 24 hours after admission and in whom long-term follow up data was available. The inclusion criteria were: rest angina within 24 hours prior to admission and at least one of the following: ST segment depression (> or = 0.5 mm), transient (< 20 min) ST-segment elevation, negative T-waves (> or = 1 mm)in at least 2 contiguous leads, positive serum cardiac markers. Patients with single-vessel CAD or qualified for conservative treatment were excluded from the study. We analysed the rate of adverse cardiac events (death, non-fatal myocardial infarction, unstable angina, repeated revascularization, cardiovascular hospitalization) at one year. The quality of life was assessed using Short-Form-36 (SF-36) questionnaire. The rate of death was 5.3% vs 9.3% (NS), myocardial infarction 3.4% vs 0% (p = 0.054), unstable angina 20.9% vs 2.8% (p = 0.0000), repeated revascularization 12.6% vs 0% (p = 0.0001) and cardiovascular hospitalization 36% vs 22.7% (p = 0.001) in the PCI and CABG group respectively. Physical Component Summary scores were 38.7 +/- 11.6 vs 43.08 +/- 9.5, p = 0.001 in the PCI and CABG group respectively. Mental Component Summary Scores were similar in both groups (46.34 +/- 13.05 vs 45.97 +/- 11.9, NS). Conclusions: Overall mortality rate was similar in both groups. PCI patients had more frequent rate of unstable angina, rate of hospitalization and repeat revascularization. This study has shown that there is a significant difference in health-related quality of life 12 months after PCI and CABG. This difference arises from better physical function (Physical Component) for CABG surgery patients compared with PCI patients. Despite impairment of the physical health status, the mental health status (Mental Component) remained similar in both groups.     

Prognostic significance of angina pectoris recurring soon after myocardial infarction

The prognostic significance of an early occurrence, or recurrence,of angina pectoris after myocardial infarction was studied in254 patients (221 male, 33 female; mean age 58±11 years).During the in-hospital rehabilitation program, 41 patients (16%)had anginal pain. The mean follow-up was 21 months (range 12–33months). Among the 254 patients, 21 died, five had recurrentmyocardial infarction, 13 had unstable angina, and 22 underwentaortocoronary bypass surgery. An early recurrence of anginapectoris was predictive of combined (medical+surgical) events(21 patients, P<0.05), medical events (11 patients, P<0.05)and surgical events (10 patients, P<0.001), but failed topredict individual death (six patients), recurrent myocardialinfarction (two patients) or unstable angina (three patients).Of the events that occurred in the 254 patients, 34% were predictedby the early recurrence of angina pectoris. Early post-infarctionangina was observed more frequently in older patients and patientswith previous history of angina pectoris. This represents animportant prognostic factor after myocardial infarction, whichdefines a high-risk group of patients requiring further investigationand appropriate therapeutic approaches.     

Prognostic value of electrocardiographic exercise testing and noninvasive assessment of left ventricular ejection fraction soon after acute myocardial infarction

To determine the relative value of clinical findings, results of low-level treadmill electrocardiographic (ECG) exercise testing and left ventricular (LV) ejection fraction (EF) for predicting cardiac events in the year after an acute myocardial infarction (AMI), 72 patients who had had an uncomplicated AMI were studied with either radionuclide angiography or 2-dimensional echocardiography to assess LVEF and a low-level treadmill exercise test before hospital discharge. All patients were followed for 1 year. Nineteen patients (26%) had at least 1 cardiac event: coronary artery bypass grafting (11 patients), recurrent AMI (6 patients) or cardiac death (6 patients). Multiple logistic regression analysis revealed that total cardiac events were predicted by exercise ECG ST-segment depression or angina, prior AMI, ventricular ectopic activity during exercise and digoxin therapy (cumulative r = 0.58, p less than 0.001). Coronary artery bypass grafting was predicted by exercise ECG ST-segment depression or angina (r = 0.29, p = 0.01). Recurrent AMI was predicted by exercise ECG ST-segment depression or angina, prior AMI and ventricular ectopic activity during exercise (cumulative r = 0.49, p less than 0.001). Cardiac death was predicted by an LVEF of 40% or less (r = 0.38, p = 0.01). The presence of both an LVEF of 40% or less and ECG ST-segment depression on treadmill exercise testing defined a subgroup of patients with a high incidence of early cardiac death (33%).(ABSTRACT TRUNCATED AT 250 WORDS)     

Prognostic significance of transient ischemic episodes: Response to treatment shows improved prognosis Results of the total ischemic burden bisoprolol study (TIBBS) follow-up

Objectives. The Total Ischemic Burden Bisoprolol Study (TIBBS) follow-up examined cardiac event rates in relation to translent ischemia and its treatment.Background. It is nuclear whether transient ischemia on the ambulatory electrocardiogram has prognostic implications in stable angina and whether medical treatment can improve the prognosis.Methods. The TIBBS trial was an 8-week, randomized, controlled comparison of the effects of bisoprolol and nifedipine on transient ischemic episodes in patients with stable angina pectoris. Of the 545 patients screened, 520 (95.4%) could be followed up. Rates of cardiac and noncardiac death, nonfatal acute myocardial infarction, hospital admission for unstable angina and need for coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty were recorded.Results. A total of 145 events occurred in 120 (23.1%) of 520 patients. Patients with more than six episodes had an event rate of 32.5% compared with 25.0% for patients with two to six episodes and 13.2% for patients with less than two episodes (p < 0.001). Hard events (death, acute myocardial infarction, hospital admission for unstable angina pectoris) were more frequent in patients with two or more ischemic episodes (12.1% vs. 4.7%, p = 0.0049). Patients with a 100% response rate of transient ischemic episodes during the TIBBS trial had a 17.5% event rate at 1 year compared with 32.3% for non-100% responders (p = 0.008). Patients receiving bisoprolol during the TIBBS trial had a lower event rate (22.1%) at 1 year than patients randomized to nifedipine (33.1%, p = 0.033).Conclusions. In patients with stable angina pectoris, frequent episodes of transient ischemia are a marker for an increased event rate. A 100% response to medical treatment reduces the event rate. The greater reduction of ischemia with bisoprolol than nifedipine during the TIBBS trial translated into animproved outcome at 1 year.     

Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis

Objectives. The aim of the study was to assess the prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography (DSE) in patients with acute myocardial infarction (AMI) treated with thrombolysis.Background. DSE can detect myocardial viability and ischemia early after AMI, but the prognostic importance of viability and ischemia in these patients has yet to be assessed.Methods. DSE was performed in 152 patients at a mean of 9 ± 5 days after a first AMI treated with thrombolysis to evaluate myocardial viability and ischemia. The patients were followed up for 15 ± 19 months.Results. On the basis of DSE results three groups of patients were identified: group 1 (95 patients, 62.5%) with myocardial viability and ischemia, group 2 with myocardial viability without ischemia (32 patients, 21%) and group 3 (25 patients, 16.5%) with no myocardial viability. During follow-up 10 patients (6.5%) had hard events, 53 (35%) developed unstable angina and 67 (44%) underwent myocardial revascularization. The rate of hard events was 10% in group 1 and 0% in group 2 and 3 patients (p < 0.05 group 1 versus group 2); group 1 patients with viability and ischemia showed a significantly higher rate of recurrence of unstable angina and myocardial revascularization procedures (40% and 60%) compared to group 2 (22% and 16%) and group 3 patients (20% and 20%). Using the Cox multivariate stepwise model, only the extent of ischemic myocardium (hazard ratio (HR) = 21.7, p = 0.02) and angina during DSE (HR = 4.45, p = 0.03) were significant predictors of hard events; an ischemic response to DSE (HR = 2.92, p = 0.001) was the most important predictor of spontaneous events, followed by ST-segment depression during DSE (HR = 1.71, p = 0.04), angina during DSE (HR = 1.53, p = 0.19) and age (HR = 0.96, p = 0.05).Conclusions. In patients with a first AMI treated with thrombolysis the presence and extent of myocardial ischemia during DSE is the most important predictor of both hard and spontaneous cardiac events, whereas myocardial viability does not have an independent prognostic value.     

Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry)

Our primary study aim was to examine extent of, and factors associated with, delay in seeking medical care in a large multinational registry of patients with acute myocardial infarction (AMI) and unstable angina pectoris. A secondary goal was to examine the relation between duration of prehospital delay and receipt and timing of coronary reperfusion strategies. Investigators from 14 countries are participating in the Global Registry of Acute Coronary Events (GRACE) project. The study sample consisted of 3,693 patients with ST-segment elevation AMI, 2,935 with non-ST-segment elevation AMI, and 3,954 patients with unstable angina hospitalized between 1999 and 2001. The average and median delay times were longest in patients with non-ST-segment elevation AMI (6.1 and 3.0 hours, respectively) followed by patients with unstable angina (5.6 and 3.0 hours) and those with ST-segment elevation AMI (4.7 and 2.3 hours). Approximately 41% of patients with ST-segment elevation AMI presented to the 94 study hospitals within 2 hours of the onset of acute coronary symptoms; this compared with approximately one third of patients with non-ST-segment elevation AMI and unstable angina. Several demographic and clinical characteristics were associated with prehospital delay. In patients with ST-segment elevation AMI, duration of prehospital delay was inversely related to the receipt of thrombolytic therapy, but was inconsistently related to the use of percutaneous coronary interventions. The results of this study demonstrate that a large proportion of patients continue to exhibit prolonged delay in seeking medical care after the onset of acute coronary symptoms and remain in need of targeted educational efforts to reduce extent of delay.     

Prevalence,characteristics, and risk stratification of electrocardiographic and symptomatic silence of myocardial ischemia despite scintigraphically evidenced ischemia in symptomatic patients presenting with severe coronary artery stenosis

Symptoms of angina pectoris and transient ST-segment depression are most commonly used to evidence acute myocardial ischemia during exercise testing. However, the diagnostic accuracy of either or both criteria in relation to clinical characteristics and the patient's exercise response has been a subject of controversy. The prevalence and severity of symptoms of angina pectoris and/or ST-segment depression were studied prospectively in 147 consecutive patients with a history of daily angina pectoris, scintigraphic evidence of exercise-induced myocardial ischemia, and coronary artery stenosis >75%. Logistic regression analysis was applied to determine absence of any or both criteria by the clinical characteristics or exercise response of the patient. During exercise testing, ST-segment response failed to prove scintigraphically evidenced myocardial ischemia in 14/147 patients (10%) and 35/147 patients (24%) when ST-segment depression ≥0.1 in either ≥1 or ≥2 ECG leads was chosen. Symptoms of angina pectoris were found to be absent in 69/147 patients (47%). Only 58 patients (40%) suffered from angina and met the ECG criterion at the time of scintigraphic myocardial ischemia. Absence of ST-segment depression was best predicted by clinical variables such as large myocardial infarction (increase: 2.6 times, p = 0.007), number of stenoses ≥2 (2.0 times, p = 0.023), and presence of diabetes mellitus (4.3 times, p = 0.035). Painless myocardial ischemia was only determined by blood response to exercising. Thus, a double product > 23 increased the risk of painless myocardial ischemia by 1.5 times (p = 0.017). In multivariate analysis, only blood pressure response, infarction size, and the number of diseased vessels were found to be independent predictors of the absence of angina pectoris or ST-segment depression during myocardial ischemia.     

Increased soluble platelet/endothelial cell adhesion molecule-1 in the early stages of acute coronary syndromes

Specific molecules including inflammatory cell adhesion molecules mediate attachment of blood leukocyte and platelets to the endothelium and mononuclear cell migration into the arterial intima. However, the clinical significance of soluble cell adhesion molecules very early in the course of acute coronary syndrome is not known. We assayed platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31), intercellular adhesion molecule-1 (ICAM-1, CD54), and P-selectin (CD62P) in plasma obtained from 20 patients within 3 h after the onset of acute myocardial infarction (AMI); 16 patients with unstable angina pectoris; 20 patients with stable angina pectoris, and 28 controls. Blood samples were obtained on hospital admission and again 1 week after onset of AMI and unstable angina, and on admission in patients with stable angina and controls. Plasma PECAM-1 concentration (ng/ml) on admission was higher in patients with AMI (25.6±4.7) and unstable angina (24.7±4.4) than in stable angina (20.5±4.4) and control (18.8±3.8) groups. In both AMI and unstable angina, plasma PECAM-1 had decreased significantly by 1 week (AMI, 20.8±4.0; unstable angina, 21.0±4.1). Plasma ICAM-1 concentration (ng/ml) on admission was higher in patients with AMI (254±70), unstable angina (264±78), and stable angina (245±68) than in controls (201±56), but did not differ between the three coronary syndromes. Plasma P-selectin concentration did not differ between the four groups, including controls. Therefore, soluble PECAM-1 concentration may be a sensitive markers providing early diagnostic aid in acute coronary syndromes.     

Continuous electrocardiographic monitoring in patients with unstable angina pectoris: Identification of high-risk subgroup with severe coronary disease,variant angina,and/or impaired early prognosis

We assessed the value of two-channel Holter monitoring during the initial hours of hospitalization in patients with unstable angina pectoris (UAP) to identify those with severe coronary artery disease (CAD), variant angina, and/or poor prognosis over the next 3 months. Accordingly, 116 UAP patients had Holter monitoring for 27 ± 7 (mean ± SD) (range 12 to 50) hours following hospitalization. Of these, 24 evolved myocardial infarction (MI) during monitoring and 92 did not. Transient ST segment alterations occurred in 21 of the 92. Of these 21, 4 had variant angina, were treated with calcium antagonists, and did well. Each of the remaining 17 had severe fixed CAD (left main or three-vessel) (n = 12) and/or poor prognosis over the 3 months after discharge as manifested by death (n = 1), MI (n = 3), and/or severe angina (n = 3). In contrast, 71 patients did not demonstrate transient ST segment alterations: none had variant angina (p < 0.001), nine had left main or three-vessel CAD (p < 0.001), and 50 were alive and well 3 months after discharge (p < 0.001). Ventricular tachycardia (VT) was demonstrated by Holter monitor in 5 of the 92 patients: four had three-vessel CAD and the other had severe persistent angina. Thus in patients hospitalized with unstable angina, transient ST segment alterations and/or VT on Holter monitor are specific predictors of “high-risk” subgroup UAP patients with left main or three-vessel CAD, variant angina, and/or impaired 3-month prognosis.     

Relation of antianginal efficacy of nifedipine to degree of coronary arterial narrowing and to presence of coronary collateral vessels

Thirty-six patients with chronic stable angina pectoris or with stable and vasospastic components of angina pectoris were classified by coronary arteriographic findings into 4 groups. Patients in group A had a single stenotic coronary artery; patients in groups B, C and D had occluded arteries, but these arteries had been collateralized to varying degrees, and an epicardial coronary steal phenomenon was possible. All patients underwent multiple exercise tests before and after randomized, double-blind, crossover treatment with 20 mg of nifedipine, 20 mg of isosorbide dinitrate, a combination of both, and placebo. Maximal and mean ST-segment depression, occurrence of angina pectoris and heart rate were evaluated. After nifedipine treatment, mean ischemic ST-segment depression was reduced 21% in group A (p less than 0.05), but was not significantly altered in the other groups (group B, 2% decrease; group C, 10% increase; group D, 3% decrease). However, isosorbide dinitrate reduced ST-segment depression significantly in all groups (group A, 29%, p less than 0.001; group B, 18%, p less than 0.01; group C, 19%, p less than 0.05; group D, 33%, p less than 0.05). The combination with nifedipine did not further improve the effect of isosorbide dinitrate. Maximal ST-segment depression and angina pectoris paralleled the changes in mean ST depression during the different medications. Heart rate at rest was not significantly changed after nifedipine treatment in any group, but increased significantly after isosorbide dinitrate treatment in groups B and C (group B, 12%, p less than 0.01; group C, 9%, p less than 0.05); heart rate during exercise did not differ significantly in any group or after any form of medication from placebo.     

Short and long term outcome of percutaneous transluminal coronary angioplasty in unstable versus stable angina pectoris: A report of the 1985–1986 nhlbi ptca registry

In a cohort of 1,720 consecutive patients from the National Heart, Lung, and Blood Institute, Percutaneous Transluminal Coronary Angioplasty (PTCA) Registry (August 1985–May 1986), we compared 768 patients (45%) with stable angina and 952 patients (55%) with unstable angina pectoris. Unstable angina patients exhibited at least one of the following characteristics: new onset angina, rapidly progressing angina, angina at rest, angina refractory to medication, variant angina, acute coronary insufficiency, or angina recurring shortly after an acute myocardial infarct. The distribution of single- and multi-vessel disease was similar among stable and unstable angina patients; multi-vessel disease predominated. Average severity of stenosis and incidence of tubular and diffuse stenosis morphology were higher among patients with unstable angina (both p<0.001). Patient success rates were similar in stable and unstable patients. However, on a per lesion basis, overall angiographic success rate and average reduction of severity of stenosis in successfully dilated lesions were significantly higher among patients with unstable angina (both p<0.001). Incidence of major patient complications (p<0.01) and of emergency coronary bypass surgery (p<0.05) were also higher in patients with unstable angina but consistent with their more precarious clinical condition and stenosis morphology. During a two year follow-up, the cumulative distributions of death, myocardial infarct, repeat PTCA, and coronary bypass surgery were not significantly different in patients with stable angina compared to patients with unstable angina. Comparison of the current PTCA Registry cohort with the cases reported in the 1979–1982 Registry revealed a 19% higher success rate for both stable and unstable angina patients. Major complication rates decreased between time periods for stable but not for unstable angina patients. Incidence of emergency bypass surgery decreased more for stable than for unstable angina patients. Coronary angioplasty is indicated in properly selected patients with unstable angina and both single-and-multi-vessel coronary disease.     

梗塞前48小时内心绞痛发作对初次心肌梗塞近期预后的影响

本文对３９７例初次心肌梗塞患者根据其发病前４８小时内有无心绞痛分组，比较其并发症和近期转归。有心绞痛组（ＰＡＰ组）１７４例，无心绞痛组（对照组）２２３例，两组基本临床情况类似，ＰＡＰ组入院４８小时内及住院期间心衰与严重心律失常发生率明显低于对照组；入院４８小时内血浆ＣＰＫ峰值及住院期病死率亦低于对照组，可能与心脏缺血预适应有关。     

急性心肌梗死再灌注治疗的临床分析

目的 探讨急性心肌梗死患者接受不同再灌注治疗的特点及近远期疗效。方法 回顾性分析2000年1月～2004年5月期间281例ST段抬高急性心肌梗死患者分别接受直接冠状动脉成形术、静脉溶栓、补救性冠状动脉成形术、冠状动脉搭桥治疗，比较接受不同再灌注治疗患者的临床特征、心肌梗死、再灌注治疗时间、冠状动脉病变特点、住院及随访期间不良心血管事件发生情况。结果 接受静脉溶栓、直接冠状动脉成形术、补救性冠状动脉成形术、冠状动脉搭桥治疗患者分别为51例、182例、34例、14例，接受再灌注治疗以男性为主，常伴有糖尿病史，补救性冠状动脉成形术组年龄偏小。心肌梗死部位无差异性，发病至入院时间无差异性，入院至再灌注治疗时间有显著性差异（P〈0.001）。冠状动脉造影示直接冠状动脉成形术组、补救冠状动脉成形术组、冠状动脉搭桥组梗死相关动脉分布、狭窄程度、病变类型无明显差异（P〉0.05），病变血管数有明显差异（P〈0．001），梗死相关动脉再通率有显著性差别（P〈0．001）。住院期间仅直接冠状动脉成形术组有4例行再次血运重建，四组患者再发心绞痛发生率无差异性，但四组患者死亡率有显著性差异。21例患者失访，随访期间四组患者再发心绞痛、再发心肌梗死、病死率均无显著性差异，直接冠状动脉成形术组因支架内再狭窄分别有6例和9例进行冠状动脉搭桥术和切割球囊＋支架植入术。结论 对急性心肌梗死患者实施不同再灌注治疗是安全有效的，应重视对合并心源性休克患者开展直接冠状动脉成形术和急症冠状动脉搭桥术。直接冠状动脉成形术组再次血运重建率高（8．2％），应用药物洗脱支架有望进一步改善预后。